These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1421451)

  • 21. [Role of computerized tomography in the densitometric assessment of lithiasis of the gallbladder].
    Polverosi R; Sbeghen R; Zambelli C; Caracciolo F; Spigariol F; Caroli A
    Radiol Med; 1992 Oct; 84(4):387-92. PubMed ID: 1455020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
    Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
    Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Orally administered gallbladder therapeutic agents, Part II: Actigall (ursodeoxycholic Acid, UDCA).
    Claussen DW
    Gastroenterol Nurs; 1993 Jun; 15(6):254-5. PubMed ID: 8323995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combined therapy with chenodeoxycholic acid and ursodeoxycholic acid of radiolucent biliary lithiasis].
    Pérez Aguilar F; Breto M; del Val A; Berenguer J
    An Med Interna; 1989 Mar; 6(3):119-24. PubMed ID: 2491184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of cholesterol gallstones with litholytic bile acids.
    Salen G; Tint GS; Shefer S
    Gastroenterol Clin North Am; 1991 Mar; 20(1):171-82. PubMed ID: 2022420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiological and ultrasonographic investigations with respect to patient selection and monitoring for chemical gallstone dissolution.
    Leuschner M; Leuschner U; Strohm WD; Trüber E; Fuchs H; Classen M
    Hepatogastroenterology; 1984 Jun; 31(3):140-3. PubMed ID: 6469205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recurrent gallstones and possibilities for treatment after successful gallstone dissolution].
    Tudyka J; Wechsler JG; Kratzer W; Ernst S; Mack C; Janowitz P; Ditschuneit H
    Med Klin (Munich); 1991 Nov; 86(11):585-8, 606. PubMed ID: 1770899
    [No Abstract]   [Full Text] [Related]  

  • 29. Changes of bile acid and lipid composition in blood and bile in the clinical course after the initiation of cheno- and ursodeoxycholic acid therapy in patients with cholesterol gallstones.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Nov; 7(6):671-83. PubMed ID: 7184199
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gall-stone dissolution treatment using cholelitholytic bile acids: experience with 24 patients.
    van Erpecum KJ; van Berge Henegouwen GP; van der Werf SD
    Neth J Med; 1989 Feb; 34(1-2):3-9. PubMed ID: 2644556
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different effects of chenodeoxycholic acid and ursodeoxycholic acid on serum lipoprotein concentrations in patients with radiolucent gallstones.
    Leiss O; von Bergmann K
    Scand J Gastroenterol; 1982 Aug; 17(5):587-92. PubMed ID: 7178821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Results of the treatment with biliary dissolvents].
    Dhumeaux D
    Rev Prat; 1992 Jun; 42(12):1478-81. PubMed ID: 1411169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The response to medical litholytic treatment of gallstones according to their specific gravity.
    Tomatsu S
    Surg Endosc; 1987; 1(2):89-92. PubMed ID: 3503370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Importance of cholegraphy for indicating litholysis].
    Wolpers C
    Rofo; 1982 Oct; 137(4):444-50. PubMed ID: 6216183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Total protein content of human gallbladder bile: relation to cholesterol gallstone disease and effects of treatment with bile acids and aspirin.
    Sahlin S
    Eur J Surg; 1996 Jun; 162(6):463-9. PubMed ID: 8817223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy of ursodeoxycholic acid in gallbladder cholesterosis accompanied by cholecystolithiasis].
    Il'chenko AA; Orlova IuN
    Eksp Klin Gastroenterol; 2003; (1):46-50, 182. PubMed ID: 12664784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Medical treatment of cholelithiasis. I. Bile acids].
    Moreno Sánchez D
    Rev Esp Enferm Dig; 1990 Feb; 77(2):159-64. PubMed ID: 2189470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Oral dissolving treatment of gallbladder calculi: focus in 1989].
    Erlinger S
    Ann Chir; 1989; 43(6):417-9. PubMed ID: 2817740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical, ultrasonographic, and roentgenographic study in 134 asymptomatic gallstone carriers. Is oral ursodeoxycholic acid treatment worthwhile?
    Lirussi F; Passera D; Iemmolo RM; Nassuato G; Okolicsanyi L
    Scand J Gastroenterol; 1993 Mar; 28(3):267-73. PubMed ID: 8446852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The content of cholylglycine in the blood serum in cholelithiasis during treatment with litholytic preparations of bile acids].
    Bocharova LV; Genia LP; Lemeshko ZA; Petrova EA
    Lab Delo; 1989; (3):59-61. PubMed ID: 2469846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.